×
Merck Basic EPS 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck basic eps for the twelve months ending September 30, 2024 was
$4.79
, a
163.19% increase
year-over-year.
Merck annual basic eps for 2023 was
$0B
, a
97.56% decline
from 2022.
Merck annual basic eps for 2022 was
$0.006B
, a
11.05% increase
from 2021.
Merck annual basic eps for 2021 was
$0.005B
, a
84.95% increase
from 2020.
View More
Merck Basic EPS 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck annual basic eps for 2023 was
$0B
, a
97.56% decline
from 2022.
Merck annual basic eps for 2022 was
$0.006B
, a
11.05% increase
from 2021.
Merck annual basic eps for 2021 was
$0.005B
, a
84.95% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$692.7B
Novo Nordisk (NVO)
$460.6B
Johnson & Johnson (JNJ)
$368.4B
AbbVie (ABBV)
$294.4B
Novartis AG (NVS)
$211.1B
AstraZeneca (AZN)
$197.8B
Pfizer (PFE)
$142.2B
Sanofi (SNY)
$121.8B
Innoviva (INVA)
$1.2B